Debu Tripathy, MD is Professor of Medicine and Chair, Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center. He received a degree in Chemical Engineering from the Massachusetts Institute of Technology and then completed medical school and an internal medicine residency at Duke University followed by a Hematology/Oncology fellowship at the University of California at San Francisco. His clinical research focuses on the evaluation and development of novel therapeutics in breast cancer, specifically, growth factor receptor pathway targeting as well as biomarkers that predict sensitivity and resistance. Dr. Tripathy has published numerous original laboratory and clinical research articles in the area of breast cancer and serves on several editorial boards, study sections, and societies as well as Editor-in-Chief of CURE Magazine. He has previously served as the Presidents of the American Society of Breast Disease and the Society of Integrative Oncology.